{"id":"W2222086386","doi":"10.1056/nejmoa1510665","title":"Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5890,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Everolimus; Nivolumab; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Cancer research; Urology; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001794338,0.0003877172,0.001607854,0.0002261908,0.000222859,0.0004758166,0.0003773333,0.0005083116,0.001466365],"category_scores_gemma":[0.002243888,0.0001798057,0.0007896853,0.0001920855,0.0003523288,0.0003693045,0.0002791364,0.001182566,0.0001761882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005529984,"about_ca_system_score_gemma":0.0009280338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005709999,"about_ca_topic_score_gemma":0.001689929,"domain_scores_codex":[0.9992083,0.0005179166,0.00006585915,0.00007152311,0.00007593576,0.00006044388],"domain_scores_gemma":[0.9989914,0.0005095302,0.000155939,0.00003123578,0.00004709217,0.0002649178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8500683,0.0071205,0.005601946,0.001050811,0.001761215,0.0001056188,0.0001606613,0.003166751,0.009235783,0.0002288856,0.0006019624,0.1208975],"study_design_scores_gemma":[0.4777265,0.4751004,0.02477371,0.0003024178,0.002575312,0.0004000893,0.0001606838,0.00702265,0.006290388,0.0006720899,0.004931584,0.00004417008],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913628,0.007016726,0.0002296513,0.0003439202,0.0001474943,0.0002369268,0.0000553815,0.00001191944,0.0005952446],"genre_scores_gemma":[0.9969739,0.001884737,0.000360185,0.0001854729,0.0001174219,0.0001447627,0.00005563921,0.000002993325,0.0002748635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001794338,"threshold_uncertainty_score":0.009489477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04492848070683175,"score_gpt":0.2874955900180906,"score_spread":0.2425671093112589,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}